Heinz‐Josef Lenz
0000-0003-2178-9568
Publication & Citation Trends
Most Cited Works
Publications
1,840 total
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer PDF
Cited by 2,028
OpenAlex
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study PDF
Cited by 2,766
OpenAlex
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy PDF
Cited by 1,568
OpenAlex
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer PDF
Cited by 872
OpenAlex
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials PDF
Cited by 819
OpenAlex
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer PDF
Cited by 719
OpenAlex
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer PDF
Cited by 791
OpenAlex
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Cited by 2,853
OpenAlex
Colorectal cancer
Cited by 1,352
OpenAlex
Research Topics
Colorectal Cancer Treatments and Studies
(968)
Genetic factors in colorectal cancer
(380)
Cancer Genomics and Diagnostics
(319)
Gastric Cancer Management and Outcomes
(286)
Cancer Treatment and Pharmacology
(259)
Frequent Co-Authors
Affiliations
Northwestern University
University of North Carolina at Chapel Hill
Goethe University Frankfurt
University of Southern California
West Virginia University